RSSPast Articles

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

| May 1, 2018 | 0 Comments

Continue Reading

Atrial Fibrillation and Injected Aripiprazole: A Case Report

Atrial Fibrillation and Injected Aripiprazole: A Case Report

| May 1, 2018 | 0 Comments

Continue Reading

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

| May 1, 2018 | 0 Comments

Continue Reading

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

| May 1, 2018 | 0 Comments

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

| May 1, 2018 | 0 Comments

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

| May 1, 2018 | 0 Comments

Continue Reading

Valbenazine and Deutetrabenazine  for Tardive Dyskinesia

Valbenazine and Deutetrabenazine for Tardive Dyskinesia

| May 1, 2018 | 0 Comments

Continue Reading

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

| May 1, 2018 | 0 Comments

Continue Reading

Letter to the Editor: Kratom and the Opioid Crisis

Letter to the Editor: Kratom and the Opioid Crisis

| May 1, 2018 | 0 Comments

Continue Reading